Skip to Content

Rule

Medical Devices; Technical Amendment

Document Details

Information about this document as published in the Federal Register.

Enhanced Content

Relevant information about this document from Regulations.gov provides additional context. This information is not part of the official Federal Register document.

Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble

AGENCY:

Food and Drug Administration, HHS.

ACTION:

Final rule; technical amendment.

SUMMARY:

The Food and Drug Administration (FDA) is amending certain medical device regulations to correct minor errors in the Code of Federal Regulations (CFR). This action is editorial in nature and is intended to provide accuracy and clarity to the Agency's regulations.

DATES:

This rule is effective March 26, 2013.

Start Further Info

FOR FURTHER INFORMATION CONTACT:

Abigail Corbin, Center for Devices and Radiological Health, Food and Drug Administration, 10903 New Hampshire Ave. Bldg. 66, rm. 4430, Silver Spring, MD 20993-0002, 301-796-9142.

End Further Info End Preamble Start Supplemental Information

SUPPLEMENTARY INFORMATION:

FDA is amending certain regulations in 21 CFR parts 814, 822, 862, 864, 866, 868, 870, 872, 874, 876, 878, 880, 882, 884, 886, 888, 890, and 892. This action corrects minor spelling errors and outdated Web site addresses affecting certain regulations regarding medical devices.

Publication of this document constitutes final action of these changes under the Administrative Procedure Act (5 U.S.C. 553). These amendments are merely correcting nonsubstantive errors. FDA therefore, for good cause, finds under 5 U.S.C. 553(b)(3)(B) and (d)(3) that notice and public comment are unnecessary.

FDA has determined under 21 CFR 25.30(i) that this final rule is of a type that does not individually or cumulatively have a significant effect on the human environment. Therefore, neither an environmental assessment nor an environmental impact statement is required. In addition, FDA has determined that this final rule contains no collection of information. Therefore, clearance by the Office of Management and Budget under the Paperwork Reduction Act of 1995 is not required.

Start List of Subjects

List of Subjects

21 CFR Part 814

  • Administrative practice and procedure
  • Confidential business information
  • Medical devices
  • Medical research
  • Reporting and recordkeeping requirements

21 CFR Part 822

  • Medical devices
  • Reporting and recordkeeping requirements

21 CFR Part 862

  • Medical devices

21 CFR Part 864

  • Blood
  • Medical devices
  • Packaging and containers

21 CFR Part 866

  • Biologics
  • Laboratories
  • Medical devices

21 CFR Part 868, 870, 872, 874, 876, 878, and 880

  • Medical devices

21 CFR Part 882

  • Medical devices
  • Neurological devices

21 CFR Part 884

  • Medical devices

21 CFR Part 886

  • Medical devices
  • Ophthalmic goods and services

21 CFR Part 888

  • Medical devices

21 CFR Part 890

  • Medical devices
  • Physical medicine devices

21 CFR Part 892

  • Medical devices
  • Radiation protection
  • X-rays
End List of Subjects

Therefore, under the Federal Food, Drug, and Cosmetic Act, and under authority delegated to the Commissioner of Food and Drugs, 21 CFR Chapter I is amended as follows:

Start Part Start Printed Page 18234

PART 870—CARDIOVASCULAR DEVICES

End Part Start Amendment Part

2. The authority citation for 21 CFR part 870 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 351, 360, 360c, 360e, 360j, 371.

End Authority Start Amendment Part

3. Amend § 870.3600 by revising the second sentence in paragraph (a) to read as follows:

End Amendment Part
External pacemaker pulse generator.

(a) Identification. * * * This device, which is used outside the body, is used as a temporary substitute for the heart's intrinsic pacing system until a permanent pacemaker can be implanted, or to control irregular heartbeats in patients following cardiac surgery or a myocardial infarction. * * *

* * * * *
Start Amendment Part

4. Amend § 870.5300 by revising the section heading to read as follows:

End Amendment Part
DC-defibrillator (including paddles).
* * * * *
Start Part

PART 882—NEUROLOGICAL DEVICES

End Part Start Amendment Part

5. The authority citation for 21 CFR part 882 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 351, 360, 360c, 360e, 360j, 371.

End Authority Start Amendment Part

6. Amend § 882.5870 by revising the second sentence in paragraph (a) to read as follows:

End Amendment Part
Implanted peripheral nerve stimulator for pain relief.

(a) Identification. * * * The stimulator consists of an implanted receiver with electrodes that are placed around a peripheral nerve and an external transmitter for transmitting the stimulating pulses across the patient's skin to the implanted receiver.

* * * * *
Start Part

PART 886—OPHTHALMIC DEVICES

End Part Start Amendment Part

7. The authority citation for 21 CFR part 886 continues to read as follows:

End Amendment Part Start Authority

Authority: 21 U.S.C. 351, 360, 360c, 360e, 360j, 371.

End Authority Start Amendment Part

8. Amend § 886.1120 by revising the section heading to read as follows:

End Amendment Part
Ophthalmic camera.
* * * * *
Start Signature

Dated: March 20, 2013.

Leslie Kux,

Assistant Commissioner for Policy.

End Signature End Supplemental Information

[FR Doc. 2013-06826 Filed 3-25-13; 8:45 am]

BILLING CODE 4160-01-P